Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
114.76 USD | -1.27% | +5.40% | +83.18% |
10/09 | Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree... | |
10/09 | Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating | MT |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
- | - | - | 7 | ||||||
25 | |||||||||
29 | |||||||||
15 | |||||||||
18 | |||||||||
21 | |||||||||
17 | |||||||||
18 | |||||||||
16 | |||||||||
25 | |||||||||
20 | |||||||||
19 | |||||||||
7 | |||||||||
- | - | - | - | ||||||
10 | |||||||||
21 | |||||||||
4 | |||||||||
13 | |||||||||
17 | |||||||||
Average | 17 | ||||||||
Weighted average by Cap. | 22 |
- Stock Market
- Equities
- PCVX Stock
- Sector Vaxcyte, Inc.
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition